FDA.reportPublic FDA data

Treanda 180 MG per 2 ML Injection

RxCUI
1805012
RxNorm name
Treanda 180 MG per 2 ML Injection
Display name
Treanda 180 MG per 2 ML Injection
Full name
Treanda 180 MG per 2 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
39d53698-57fa-7c99-fc5b-f52a55684826Treanda 180 MG in 2 ML Injection [PSN] · 2 ML bendamustine hydrochloride 90 MG/ML Injection [Treanda] [SBD] · Treanda 180 MG per 2 ML Injection [SY]326These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA ® (bendamustine hydrochloride) injection, for intravenous use TREANDA ® (bendamustine hydrochloride) for injection, for intravenous use Initial U.S. Approval: 200820221027